The PD-1 and PD-L1 axis between T cells and APCs or T cells and tumor cells contributes to the downregulation of immunity; thus, inhibition of signaling between PD-1 and PD-L1 could enhance T cell functionality and improve the treatment of disease51–54. The gene discussed is CD274; the disease is neoplasm.